AOD-9604: Frequently Asked Questions
The 10 most common questions about AOD-9604 therapy, answered in plain language.
1.What is AOD-9604?
AOD-9604 (Anti-Obesity Drug 9604) is a synthetic peptide fragment derived from the C-terminal end of human growth hormone, specifically amino acids 177-191, with an added tyrosine residue. It was developed by Professor Frank Ng at Monash University in Australia. AOD-9604 retains the fat-reducing activity of growth hormone without its growth-promoting or diabetogenic effects, meaning it does not raise IGF-1 levels, affect blood sugar, or stimulate muscle or bone growth. It received GRAS (Generally Recognized as Safe) status from the FDA in 2010 as a food additive, though it is not FDA-approved as a drug.
2.What is AOD-9604 commonly used for?
AOD-9604 is commonly sought for targeted fat loss, particularly for individuals who want the lipolytic (fat-burning) properties of growth hormone without the broader hormonal effects. It has been associated with enhanced fat metabolism by stimulating lipolysis and inhibiting lipogenesis (the conversion of food into stored fat). Patients often report reductions in stubborn fat deposits, particularly in the abdominal area. Research suggests AOD-9604 may also have cartilage repair properties, and it has been explored in clinical trials for osteoarthritis of the knee. Some practitioners use it as part of body composition optimization programs.
3.Is AOD-9604 safe?
AOD-9604 has a strong safety profile, bolstered by its FDA GRAS designation and multiple human clinical trials. Because it does not affect IGF-1 levels, blood glucose, or insulin sensitivity, it avoids the metabolic risks associated with full-length growth hormone or growth hormone secretagogues. Clinical trials involving oral and injectable AOD-9604 reported no significant adverse effects compared to placebo. The peptide's selective mechanism, targeting fat metabolism without growth-promoting activity, makes it one of the safer options in the weight management peptide space.
Have more questions? Get matched with a provider who specializes in AOD-9604 →
4.What are the potential side effects of AOD-9604?
Side effects of AOD-9604 are minimal based on available clinical trial data. The most commonly reported effects include injection site reactions (redness, mild swelling, or irritation), mild headache, and occasional indigestion. Some users report a temporary sensation of warmth or flushing after injection. Because AOD-9604 does not elevate growth hormone or IGF-1, it does not carry the water retention, joint pain, or insulin resistance risks associated with GH therapies. It is considered well-tolerated even in extended use scenarios, though long-term data beyond clinical trial durations is limited.
5.How is AOD-9604 administered?
AOD-9604 is primarily administered via subcutaneous injection in the abdominal area, ideally near the target fat deposits, though systemic absorption means the location is not as critical as with some local therapies. Standard dosing is 300 mcg injected once daily, typically in the morning on an empty stomach, as food intake, particularly carbohydrates, may reduce its effectiveness. Some practitioners use higher doses up to 500 mcg daily. The peptide is supplied as a lyophilized powder for reconstitution. Oral formulations have also been studied in clinical trials, but the injectable route is more common in clinical practice.
6.How long does AOD-9604 take to work?
Initial changes in how clothing fits and subjective body composition improvements are often reported within two to three weeks of consistent daily use. Measurable reductions in body fat, confirmed by DEXA scans or body composition analysis, typically require six to twelve weeks. AOD-9604 works gradually by shifting the balance between fat storage and fat breakdown, so results accumulate over time rather than appearing dramatically. Most clinical protocols run for twelve weeks, and the peptide is most effective when combined with regular exercise and a calorie-controlled diet.
Have more questions? Get matched with a provider who specializes in AOD-9604 →
7.How much does AOD-9604 cost?
AOD-9604 from a compounding pharmacy typically costs between $100 and $250 for a 30-day supply at standard dosing. A 5 mg vial, which lasts approximately 15-17 days at 300 mcg daily, generally runs $80 to $150. Some clinics offer it as part of weight management programs bundled with consultation, monitoring, and dietary guidance for $250 to $500 per month. Compared to GLP-1 agonists like Semaglutide, AOD-9604 is significantly less expensive, though its weight loss effects are generally considered more modest.
8.Do I need a prescription for AOD-9604?
Yes, injectable AOD-9604 requires a prescription from a licensed healthcare provider and is obtained through compounding pharmacies. Despite its GRAS designation as a food additive, its use as an injectable peptide for fat loss falls under medical oversight. Providers specializing in weight management, anti-aging, and peptide therapy are the most common prescribers. Baseline body composition measurements and metabolic labs are often recommended before starting to enable objective tracking of progress.
9.Can AOD-9604 be combined with other peptides?
AOD-9604 is commonly combined with CJC-1295/Ipamorelin for individuals who want both fat loss and the broader benefits of growth hormone optimization, including improved sleep, recovery, and lean mass. Since AOD-9604 does not affect GH or IGF-1 levels, there is no overlapping mechanism with secretagogues. Some practitioners stack it with Semaglutide or Tirzepatide for a multi-mechanism approach to weight loss, using AOD-9604 for direct lipolysis and GLP-1 agonists for appetite suppression. BPC-157 may be added for gut health support, particularly in comprehensive body composition programs.
Have more questions? Get matched with a provider who specializes in AOD-9604 →
10.Who is a good candidate for AOD-9604?
Individuals with stubborn fat deposits who want a targeted fat loss approach without the systemic hormonal effects of growth hormone therapy are ideal candidates. AOD-9604 is particularly suitable for people who are near their target weight but struggling with specific areas of resistant fat. Those who cannot use or prefer to avoid GLP-1 agonists due to gastrointestinal sensitivity may find AOD-9604 to be a gentler alternative. It is not a substitute for addressing fundamental lifestyle factors like diet and exercise, and individuals with significant obesity may find more robust results with other interventions. Those with active cancer should consult their provider before use.
Still have questions about AOD-9604?
A qualified provider can give you personalized answers based on your health history and goals.
Get Matched With a AOD-9604 ProviderLearn More About AOD-9604
Medical Disclaimer: This content is for informational purposes only and does not constitute medical advice, diagnosis, or treatment. Peptide therapies should only be administered by licensed healthcare providers. Always consult with a qualified healthcare professional before starting any new treatment. PeptideLeads is a marketing agency and does not provide medical services.